These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8290946)

  • 1. ApoE, amyloid, and Alzheimer's disease.
    Hardy J
    Science; 1994 Jan; 263(5146):454-5. PubMed ID: 8290946
    [No Abstract]   [Full Text] [Related]  

  • 2. New piece in Alzheimer's puzzle.
    Travis J
    Science; 1993 Aug; 261(5123):828-9. PubMed ID: 8346434
    [No Abstract]   [Full Text] [Related]  

  • 3. Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications.
    Kaplitt M; Gouras GK; Makimura H; Jovanovic J; Sweeney D; Greengard P; Relkin NR; Gandy S
    Ann N Y Acad Sci; 1996 Dec; 802():42-9. PubMed ID: 8993483
    [No Abstract]   [Full Text] [Related]  

  • 4. [Apolipoprotein E4 and late-onset Alzheimer's disease].
    Tamaoka A
    Nihon Rinsho; 1994 Dec; 52(12):3257-65. PubMed ID: 7853720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner.
    Lauderback CM; Kanski J; Hackett JM; Maeda N; Kindy MS; Butterfield DA
    Brain Res; 2002 Jan; 924(1):90-7. PubMed ID: 11743999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid beta-protein, APOE genotype and head injury.
    Nicoll JA; Roberts GW; Graham DI
    Ann N Y Acad Sci; 1996 Jan; 777():271-5. PubMed ID: 8624097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApoE4: is it the absence of good or the presence of bad?
    Ashford JW
    J Alzheimers Dis; 2002 Jun; 4(3):141-3. PubMed ID: 12226532
    [No Abstract]   [Full Text] [Related]  

  • 9. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
    Poirier J
    Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New gene tied to common form of Alzheimer's.
    Marx J
    Science; 1998 Jul; 281(5376):507, 509. PubMed ID: 9705719
    [No Abstract]   [Full Text] [Related]  

  • 11. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
    Strittmatter WJ; Saunders AM; Schmechel D; Pericak-Vance M; Enghild J; Salvesen GS; Roses AD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1977-81. PubMed ID: 8446617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease: treatment research finds new targets.
    Hodes RJ
    J Am Geriatr Soc; 1994 Jun; 42(6):679-81. PubMed ID: 8201156
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain.
    Näslund J; Thyberg J; Tjernberg LO; Wernstedt C; Karlström AR; Bogdanovic N; Gandy SE; Lannfelt L; Terenius L; Nordstedt C
    Neuron; 1995 Jul; 15(1):219-28. PubMed ID: 7619525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's disease: A role for high-density lipoproteins?
    Mulder M; Terwel D
    Haemostasis; 1998; 28(3-4):174-94. PubMed ID: 10420065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
    Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Small GW; Roses AD; Haines JL; Pericak-Vance MA
    Science; 1993 Aug; 261(5123):921-3. PubMed ID: 8346443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.
    Hyman BT; Gomez-Isla T; West H; Briggs M; Chung H; Growdon JH; Rebeck GW
    Ann N Y Acad Sci; 1996 Jan; 777():158-65. PubMed ID: 8624079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases.
    Pickering-Brown SM; Mann DM; Bourke JP; Roberts DA; Balderson D; Burns A; Byrne J; Owen F
    Lancet; 1994 May; 343(8906):1155. PubMed ID: 7818636
    [No Abstract]   [Full Text] [Related]  

  • 20. Haptoglobin interacts with apolipoprotein E and beta-amyloid and influences their crosstalk.
    Spagnuolo MS; Maresca B; La Marca V; Carrizzo A; Veronesi C; Cupidi C; Piccoli T; Maletta RG; Bruni AC; Abrescia P; Cigliano L
    ACS Chem Neurosci; 2014 Sep; 5(9):837-47. PubMed ID: 25058565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.